Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 9;12(2):447.
doi: 10.3390/diagnostics12020447.

Evaluation and Modelling of the Performance of an Automated SARS-CoV-2 Antigen Assay According to Sample Type, Target Population and Epidemic Trends

Nicolas Yin  1 , Cyril Debuysschere  1 , Valery Daubie  1 , Marc Hildebrand  2 , Charlotte Martin  3 , Sonja Curac  4 , Fanny Ponthieux  1 , Marie-Christine Payen  3 , Olivier Vandenberg  5   6   7 , Marie Hallin  1   5
Affiliations

Evaluation and Modelling of the Performance of an Automated SARS-CoV-2 Antigen Assay According to Sample Type, Target Population and Epidemic Trends

Nicolas Yin et al. Diagnostics (Basel). .

Abstract

The Lumipulse® G SARS-CoV-2 Ag assay performance was evaluated on prospectively collected saliva and nasopharyngeal swabs (NPS) of recently ill in- and outpatients and according to the estimated viral load. Performances were calculated using RT-PCR positive NPS from patients with symptoms ≤ 7 days and RT-PCR negative NPS as gold standard. In addition, non-selected positive NPS were analyzed to assess the performances on various viral loads. This assay yielded a sensitivity of 93.1% on NPS and 71.4% on saliva for recently ill patients. For NPS with a viral load > 103 RNA copies/mL, sensitivity was 96.4%. A model established on our daily routine showed fluctuations of the performances depending on the epidemic trends but an overall good negative predictive value. Lumipulse® G SARS-CoV-2 assay yielded good performance for an automated antigen detection assay on NPS. Using it for the detection of recently ill patients or to screen high-risk patients could be an interesting alternative to the more expensive RT-PCR.

Keywords: COVID-19; SARS-CoV-2; assay; diagnostic; model; test.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Receiver Operating Curve (ROC) analysis of antigen quantification (Ag) on nasopharyngeal swabs (NPS) vs. RT-PCR on NPS as gold standard.
Figure 2
Figure 2
Receiver Operating Curve (ROC) analysis of antigen quantification (Ag) on saliva vs. RT-PCR on nasopharyngeal swabs (NPS) as gold standard.
Figure 3
Figure 3
Modelling SARS-CoV-2 automated antigen detection performance on epidemic trends. Data computed from 1 May 2020 to 30 October 2021 using a backward sliding window of 14 days (14-day Se: 14-day sensitivity, 14-day PPV: 14-day Positive Predictive Value, 14-day NPV: 14-day Negative Predictive Value).
See this image and copyright information in PMC

References

    1. Williams E., Bond K., Zhang B., Putland M., Williamson D.A. Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2. J. Clin. Microbiol. 2020;58:e00776-20. doi: 10.1128/JCM.00776-20. - DOI - PMC - PubMed
    1. Han P., Ivanovski S. Saliva—Friend and Foe in the COVID-19 Outbreak. Diagnostics. 2020;10:290. doi: 10.3390/diagnostics10050290. - DOI - PMC - PubMed
    1. World Health Organization . Antigen-Detection in the Diagnosis of SARS-CoV-2 Infection—Interim Guidance. World Health Organization; Geneva, Switzerland: 2021.
    1. European Centre for Disease Prevention and Control . Options for the Use of Rapid Antigen Tests for COVID-19 in the EU/EEA and the UK. European Centre for Disease Prevention and Control; Solna, Sweden: 2020.
    1. Hirotsu Y., Maejima M., Shibusawa M., Nagakubo Y., Hosaka K., Amemiya K., Sueki H., Hayakawa M., Mochizuki H., Tsutsui T., et al. Comparison of Automated SARS-CoV-2 Antigen Test for COVID-19 Infection with Quantitative RT-PCR Using 313 Nasopharyngeal Swabs, Including from Seven Serially Followed Patients. Int. J. Infect. Dis. 2020;99:397–402. doi: 10.1016/j.ijid.2020.08.029. - DOI - PMC - PubMed

LinkOut - more resources